Paul Chan

Paul Chan

Quality Assurance at Anchor Fabrication Ltd

Location:
1200 Lawson Road, Fort Worth, Texas, United States
HQ Phone:
(817) 232-4575

General Information

Experience

Vice President, Medical Affairs, Internal Medicine - Janssen Pharmaceuticals Inc

Chief Medical Officer, Vice President - Regulatory Affairs

Hiring Manager for TAL Metabolics Search - Ortho-McNeil Pharmaceutical , Inc.

Chief Medical Officer - Tengion , Inc.

Vice President, Global Health Outcomes and Strategic Pricing - Genzyme Corporation

Education

M.D.

Recent News  

http://phx.corporate-ir.net/phoenix.zhtml?c=218965&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTY3MjQzMDgmRFNFUT0xJlNFUT0xMTAmU1FERVNDPVNFQ1RJT05fUEFHRSZleHA9JnN1YnNpZD01Nw%3d%3d

We entered into stock repurchase agreements with our former Chief Medical Officer, Paul Chang, MD, and our former Vice President, Business Development, George Landau, pursuant to which we repurchased certain vested shares of restricted stock at a purchase price equal to the fair market value of such shares on the repurchase date and unvested shares of restricted stock at a purchase price per share equal to the par value of such share.

Read More
http://phx.corporate-ir.net/phoenix.zhtml?c=218965&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTY4ODI2OTUmRFNFUT0xJlNFUT0xMTkmU1FERVNDPVNFQ1RJT05fUEFHRSZleHA9JnN1YnNpZD01Nw%3d%3d

We entered into stock repurchase agreements with our former Chief Medical Officer, Paul Chang, MD, and our former Vice President, Business Development, George Landau, pursuant to which we repurchased certain vested shares of restricted stock from Dr. Chang at a purchase price equal to the fair market value of such shares on the repurchase date for an aggregate repurchase price of $93,951.60 and unvested shares of restricted stock from each of Dr. Chang and Mr. Landau at a purchase price per share equal to the par value of such share, for an aggregate amount of $204.74 and $11.92, respectively.
We entered into stock repurchase agreements with our former Chief Medical Officer, Paul Chang, MD, and our former Vice President, Business Development, George Landau, pursuant to which we repurchased certain vested shares of restricted stock from Dr. Chang at a purchase price equal to the fair market value of such shares on the repurchase date for an aggregate repurchase price of $93,951.60 and unvested shares of restricted stock from each of Dr. Chang and Mr. Landau at a purchase price per share equal to the par value of such share, for an aggregate amount of $204.74 and $11.92, respectively.

Read More
http://www.ascoalition.com/?tag=replica-watch

"Shorter hospital stays following hip and knee replacement have made prevention of venous blood clots" a concern for patients, said Paul Chang, a vice-president for J&J's Janssen Pharmaceuticals unit, in the statement.

Read More

Browse ZoomInfo’s Directories